Related Experiment Video

Updated: Jul 8, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

[Inhibitory effect of KAI1 gene on breast cancer cell growth in vitro]

Dan Lu1, Wen-xiu Wang, Yu-qing Xu

  • 1Department of Oncology, the Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China. ludan1972@medmail.com.cn

Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|January 24, 2008
PubMed
Abstract

Insights

The KAI1 gene significantly inhibits breast cancer cell proliferation and invasion in vitro. Overexpression of KAI1 alters cell cycle distribution, suggesting a role in suppressing tumor growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Breast cancer is a leading cause of mortality in women worldwide.
  • The KAI1 gene, also known as CD82, is a metastasis suppressor gene.
  • Understanding KAI1's role in breast cancer is crucial for developing new therapeutic strategies.

Purpose of the Study:

  • To investigate the inhibitory effect of the KAI1 gene on breast cancer cell growth and metastasis in vitro.
  • To determine the impact of KAI1 gene expression on cell cycle progression.

Main Methods:

  • Transfection of MDA-MB-231 human breast cancer cells with the KAI1 gene.
  • Western blot analysis to confirm KAI1 protein expression.
  • MTT assay and colony-forming tests for proliferation assessment.
  • Cell adhesion and invasion assays to evaluate metastatic potential.
  • Flow cytometry to analyze cell cycle distribution.

Main Results:

  • Stable KAI1 gene transfection resulted in significant overexpression of KAI1 protein.
  • KAI1 transfection markedly reduced breast cancer cell proliferation and colony formation (P < 0.05).
  • Cell adhesion and invasion capabilities were significantly decreased in KAI1-transfected cells (P < 0.05).
  • Flow cytometry showed an increase in G0/G1 phase cells and a decrease in G2/M phase cells in the KAI1 group.

Conclusions:

  • The KAI1 gene effectively suppresses the invasive and proliferative abilities of human breast cancer cells in vitro.
  • KAI1 may inhibit proliferation by altering the cell cycle pattern, specifically by promoting G0/G1 arrest.
  • These findings highlight KAI1 as a potential therapeutic target for breast cancer treatment.

More Related Videos

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...